Sputum-free Diagnostis of TB
Launched by RESEARCH CENTER BORSTEL · Aug 12, 2025
Trial Information
Current as of August 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying new ways to diagnose tuberculosis (TB) without needing patients to cough up sputum (mucus from the lungs), which can be hard for some people to do. Researchers are collecting samples like blood, urine, stool, and sputum from patients who might have TB to look for special markers that could help detect the disease more easily and less invasively. The goal is to find reliable tests that work even when sputum isn’t available, making diagnosis simpler and more comfortable.
Adults 18 years or older who have suspected or confirmed TB, or who have another lung infection, may be eligible to join. Participants will provide these samples just once, and no extra medical procedures will be done beyond their routine care. The study is taking place at the University Medical Center Hamburg-Eppendorf and is currently looking for volunteers. Pregnant individuals and those unable to give consent cannot participate. This study might help improve TB diagnosis in the future, especially for patients who find it difficult to give sputum samples.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Suspected pulmonary or extrapulmonary tuberculosis, or confirmed pulmonary or extrapulmonary tuberculosis with less than 7 days of anti-tuberculosis treatment, OR other pulmonary infection (control group).
- • Age ≥ 18 years
- • Ability to provide informed consent
- • Willingness to participate in the study
- Exclusion Criteria:
- • Lack of ability to provide informed consent
- • Age \< 18 years
- • Pregnancy
About Research Center Borstel
Research Center Borstel is a leading institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Renowned for its expertise in respiratory diseases and infectious diseases, the center conducts rigorous scientific studies that adhere to the highest ethical and regulatory standards. With a multidisciplinary team of experienced researchers and healthcare professionals, Research Center Borstel aims to translate groundbreaking findings into effective treatments, contributing significantly to the global medical community. The center fosters collaboration with academic institutions, pharmaceutical companies, and healthcare organizations to enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamburg, , Germany
Patients applied
Trial Officials
Christoph Lange, Prof. Dr. Dr. h.c.
Study Chair
Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center
Marylyn Martina Addo, Prof. Dr.
Study Chair
Institute for Infection Research and Vaccine Development, University Medical Center Hamburg-Eppendorf
Stefan Schmiedel, Dr. med.
Study Chair
Division of Infectious Diseases, I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported